Research and Development Day to be held on February 25 at 9 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALNY:
- Alnylam price target raised to $385 from $384 at Canaccord
- Alnylam Pharma: Hold Rating Due to Stable Financials and Uncertain Pipeline Prospects
- Alnylam Pharmaceuticals’ Earnings Call Highlights Strong Growth
- Alnylam price target lowered to $300 from $310 at Scotiabank
- Strong Buy Recommendation for Alnylam Pharma Amid Upcoming PDUFA Date and Promising Growth Prospects